H-GQKMNAQAI-OH

Ref. 3D-PP44261

Informations sur le produit

• Nom: H-GQKMNAQAI-OH
• Synonymes: NH2-Gly-Gln-Lys-Met-Asn-Ala-Gln-Ala-Ile-OH

Description

Peptide H-GQKMNAQAI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GQKMNAQAI-OH include the following: Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation YL Chen, MC Chang, YC Chiang, HW Lin , NY Sun - Cancer Letters, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0304383518302295 Endogenous antitumor immunity elicited by adoptively transferred lymphocytes through CCL5 and CD40L signaling, and dendritic cell depletion YC Nesbeth - 2010 - search.proquest.comhttps://search.proquest.com/openview/011c29d48b940897118330002093ccb7/1?pq-origsite=gscholar&cbl=18750 In situ Stimulation of CD40 and Toll-like Receptor 3 Transforms Ovarian Cancer-Infiltrating Dendritic Cells from Immunosuppressive to Immunostimulatory Cells UK Scarlett, JR Cubillos-Ruiz , YC Nesbeth - Cancer research, 2009 - AACRhttps://aacrjournals.org/cancerres/article-abstract/69/18/7329/549972 Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS S Zhang, LK Yong, D Li, R Cubas, C Chen, Q Yao - PLoS One, 2013 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0068303 Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine MC Chang, YL Chen, YC Chiang - American Journal of , 2016 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859650/ Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator MC Chang, YL Chen, YC Chiang, TC Chen, YC Tang - Gene Therapy, 2016 - nature.comhttps://www.nature.com/articles/gt201585 Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer M Li , U Bharadwaj , R Zhang, S Zhang, H Mu - Molecular cancer , 2008 - AACRhttps://aacrjournals.org/mct/article-abstract/7/2/286/93113 Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs L Lu, X Xu, B Zhang, R Zhang, H Ji, X Wang - Journal of translational , 2014 - Springerhttps://link.springer.com/article/10.1186/1479-5876-12-36 Insufficiency of compound immune checkpoint blockade to overcome engineered T cell exhaustion in pancreatic cancer IM Stromnes , A Hulbert, MR Rollins - for Immunotherapy of , 2022 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883283/ Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity E Huarte , JR Cubillos-Ruiz , YC Nesbeth, UK Scarlett - Cancer research, 2008 - AACRhttps://aacrjournals.org/cancerres/article-abstract/68/18/7684/541247

• Marque: Biosynth